TUESDAY, Sept. 22, 2020 — Cancer patients treated one to three months prior to COVID-19 diagnosis and those treated with chemoimmunotherapy have the highest 30-day mortality, according to a study presented at the annual meeting
COVID-19 has touched almost every country around the world since it emerged months ago. As of September 9, 2020, 27.6 million people have been infected with the SARS-CoV-2 virus, and there have been 898,000 deaths.
(HealthDay)—Severe hearing impairment (HI) in childhood cancer survivors is associated with neurocognitive deficits, according to a study recently published in JAMA Oncology. Johnnie K. Bass, Ph.D., from St. Jude Children’s Research Hospital in Memphis, Tennessee,
The primacy of preserving your health for as long as possible becomes more urgent as you get older. Life experience teaches you that there are numerous diseases that threaten your life. While you cannot fully
Hypermutation is an unusual occurence that can lead to many nearby mutations at once, severely damaging our genetic material and potentially causing cancer. The best known type of local hypermutation, called a mutation shower or
More than 200 genes with novel and known roles in glioblastoma—the most aggressive type of brain cancer—offer promising new drug targets. Researchers from the Wellcome Sanger Institute, Addenbrooke’s Hospital and their collaborators engineered a new
New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent disease in prostate cancer patients. In initial results from a multicenter trial assessing the impact of 18F-DCFPyL prostate-specific membrane
The makers of Roundup weed killer will pay up to $10.9 billion to settle multiple ongoing lawsuits and thousands of claims from people who say that the product caused their cancer. Bayer, a pharmaceutical company
Bowel cancer is one of the most common cancers to be diagnosed in the UK. You should consider speaking to a doctor if you notice that you’re making more trips to the toilet than normal.
A cutting-edge “lab-on-a-chip” has shown promise in detecting early breast cancers and tumors that have developed in other parts of the body. Roughly the size of a glass microscope slide, the EV-CLUE uses nanotechnology to